<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04180345</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A01520-57</org_study_id>
    <nct_id>NCT04180345</nct_id>
  </id_info>
  <brief_title>Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBD</brief_title>
  <acronym>FLARE_IBD</acronym>
  <official_title>Flare_IBD: Development and Validation of a Questionnaire Based on Patients' Messages on an Internet Forum for Early Detection of Flare in Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Fran√ßois Aupetit, Paris, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lorraine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease
      (IBD) are chronic disabling conditions characterized by flares followed by periods of
      remission. However, IBD patients are seen every 3 to 6 months in the outpatient clinic, and
      the occurrence of a flare between two outpatient visits is not captured. In the current state
      of knowledge, there is no validated patient-reported outcome (PRO) tool to measure the
      phenomenon of flare in IBD. This study aimed to use an innovative methodology to collect
      messages posted by patients in an Internet forum for developing and validating a PRO
      measuring flare in IBD.

      The design involves 1) Engineering sciences for scraping extraction of messages posted in an
      Internet forum and for Identification of messages related to flare, 2) Qualitative methods
      for thematic content analyze of the messages posted, for candidate items generation, for
      items selection (Delphi process) and for items adjustment (&quot;think aloud&quot; interviews), 3)
      Quantitative methods for psychometric validation of the PRO.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Scale calibration of the new developped questionnaire</measure>
    <time_frame>About 30 minutes</time_frame>
    <description>Weighing scale calibration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Construct validity of the new developped questionnaire</measure>
    <time_frame>About 30 minutes</time_frame>
    <description>Exploratory factor analysis, discriminant validity by Kruskal-Wallis tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Convergence proprieties of the new developped questionnaire</measure>
    <time_frame>about 30 minutes</time_frame>
    <description>Convergence test of Flare-IBD scores with objective biological markers and clinical markers used in routine clinical practice</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproductibility of the new developped questionnaire</measure>
    <time_frame>Up to 8 days</time_frame>
    <description>Investigation of test-retest reliability with a second questionnaire administered 8 days later.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>Validation of the questionnaire</arm_group_label>
    <description>Items reduction, ajustment and psychometric validation of the questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychometric validation of the questionnaire</intervention_name>
    <description>Delph Process : expert panel will include HCPs and patients. They will evaluate the relevance of items on a Likert scale (HCPs N = 25 ; Patients N = 25 ) &quot;Think aloud&quot; interviews (N = 10 patients) Psychometric validation ( N = 200 patients)</description>
    <arm_group_label>Validation of the questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease
        are chronic disabling conditions characterized by flares followed by periods of remission.
        To the current state of knowledge, there is no validated patient-reported outcome (PRO)
        tool to measure the phenomenon of flare in inflammatory bowel disease. This study aimed to
        use an innovative methodology to collect messages posted by patients in an Internet forum
        for developing and validating a PRO measuring flare in inflammatory bowel disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Every patient consulting the gastroenterology unit of Nancy University Hospital with a
             confirmed IBD diagnosis, regardless of the patient's state or treatment will be
             considered for inclusion

        Exclusion Criteria:

          -  patients with a diagnosis &lt; 3 months.

          -  Protected persons (minors, adults under guardianship, pregnant or breastfeeding women,
             people living in a public health or social institution, patients in an emergency
             situation, incarcerated individuals)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan Epstein, MD, PhD</last_name>
    <phone>0033382852342</phone>
    <email>j.epstein@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laetitia Ricci, PhD</last_name>
    <phone>0033382852342</phone>
    <email>l.ricci@chru-nancy.fr</email>
  </overall_contact_backup>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 23, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2019</study_first_posted>
  <last_update_submitted>November 26, 2019</last_update_submitted>
  <last_update_submitted_qc>November 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Flare</keyword>
  <keyword>Inflammatory Bowel Diseases</keyword>
  <keyword>Questionnaire</keyword>
  <keyword>Internet</keyword>
  <keyword>Mixed methods</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

